Rossari Biotech Limited Stock Fundamentals

ROSSARI Stock   826.15  18.40  2.18%   
Rossari Biotech Limited fundamentals help investors to digest information that contributes to Rossari Biotech's financial success or failures. It also enables traders to predict the movement of Rossari Stock. The fundamental analysis module provides a way to measure Rossari Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rossari Biotech stock.
As of now, Rossari Biotech's Minority Interest is increasing as compared to previous years.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Rossari Biotech Limited Company Return On Equity Analysis

Rossari Biotech's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Rossari Biotech Return On Equity

    
  0.13  
Most of Rossari Biotech's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rossari Biotech Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Rossari Total Stockholder Equity

Total Stockholder Equity

11 Billion

As of now, Rossari Biotech's Total Stockholder Equity is increasing as compared to previous years.
Based on the latest financial disclosure, Rossari Biotech Limited has a Return On Equity of 0.1324. This is 85.45% lower than that of the Chemicals sector and 97.75% lower than that of the Materials industry. The return on equity for all India stocks is 142.71% lower than that of the firm.

Rossari Biotech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Rossari Biotech's current stock value. Our valuation model uses many indicators to compare Rossari Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rossari Biotech competition to find correlations between indicators driving Rossari Biotech's intrinsic value. More Info.
Rossari Biotech Limited is rated fourth in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about  0.56  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Rossari Biotech Limited is roughly  1.80 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Rossari Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Rossari Biotech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Rossari Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rossari Biotech's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Rossari Biotech could also be used in its relative valuation, which is a method of valuing Rossari Biotech by comparing valuation metrics of similar companies.
Rossari Biotech is currently under evaluation in return on equity category among its peers.

Rossari Fundamentals

About Rossari Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Rossari Biotech Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rossari Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rossari Biotech Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue125.1 M118.8 M
Total Revenue18.3 B10 B
Cost Of Revenue15.1 B15.9 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Rossari Stock

Rossari Biotech financial ratios help investors to determine whether Rossari Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rossari with respect to the benefits of owning Rossari Biotech security.